Ronald M. Lindsay

Directeur Général chez Zebra Biologics, Inc.

Profil

Ronald M.
Lindsay currently works at Zebra Biologics, Inc., as Chairman & Chief Executive Officer, HistoRx, Inc., as Director, Depixus SAS, as Director, and Neurocentrx Pharma Ltd., as Director.
Dr. Lindsay also formerly worked at ArQule, Inc., as Director, Sequenom, Inc., as Director from 2013 to 2016, Neuro3D SA, as Director, Regeneron Pharmaceuticals, Inc., as Vice President-Neurobiology in 1997, Millennium Pharmaceuticals, Inc., as Senior Vice President-Biotherapeutics from 1997 to 2000, diaDexus, Inc., as CSO, Vice President-Research & Development from 2000 to 2004, and Sandoz Institute for Medical Research, as Head-Cell Biology from 1984 to 1989.
Dr. Lindsay received his undergraduate degree from the University of Glasgow and doctorate degree from the University of Calgary.

Postes actifs de Ronald M. Lindsay

Sociétés	Poste	Début
HistoRx, Inc.	Directeur/Membre du Conseil	-
Neurocentrx Pharma Ltd.	Directeur/Membre du Conseil	-
Zebra Biologics, Inc.	Directeur Général	-
Depixus SAS	Directeur/Membre du Conseil	-

Anciens postes connus de Ronald M. Lindsay

Sociétés	Poste	Fin
SEQUENOM, INC.	President	21/12/2009
Neuro3D SA	Directeur/Membre du Conseil	21/10/2013
diaDexus, Inc. /Old/	Directeur Technique/Scientifique/R&D	01/01/2004
Millennium Pharmaceuticals, Inc.	Corporate Officer/Principal	01/01/2000
REGENERON PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/1997